Cellay Inc. is a company that specializes in the manufacture and marketing of Same Day OligoFISH® Probes as analyte specific reagents (ASRs) for chromosome enumeration. Founded in 2009, the company's probes are chemically synthesized oligonucleotides, directly labeled with one fluorophore per probe, and manufactured under cGMP conditions in an FDA-registered facility. The innovative probes require lower stringency, with the ability to hybridize to target DNA in minutes instead of hours, thus increasing throughput and reducing costs while seamlessly integrating into existing workflow and imaging equipment. Supported by an experienced sales and technical staff, Cellay Inc. is committed to providing comprehensive customer support. Despite the absence of specific information on industries and headquarters, the potential of the company's technology could attract significant interest from investors and industry players, as it fills a crucial need in genetic analysis and has the potential to disrupt the market. With potential investor interest, a strategic partnership or investment could propel Cellay Inc. towards rapid growth and commercial success.
There is no investment information
No recent news or press coverage available for Cellay Inc..